Comparison of Inflammatory Markers and Incidence of Comorbidities in Patients on Antiretroviral Therapy With Second-generation Anti-integrase Drugs on Triple Versus Dual Therapy

NARecruitingINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

February 16, 2023

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2026

Conditions

Hiv

Interventions

OTHER

plasma inflammatory markers

Evolution of different plasma inflammatory markers (CRP, IL6, D-Dimers, CD14s, CD163, IL-1, IP-10, MCP-1, IL-18, IFAB)

OTHER

CD4/CD8 ratio

Evolution of CD4/CD8 ratio

Trial Locations (2)

RECRUITING

CH Simone VEIL, Cannes

RECRUITING

CHU Nice, Nice

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nice

OTHER